Liposomes as vehicles for targeted therapy of cancer. Part 1: preclinical development.
Harrington
K J
KJ
ICRF Oncology Unit, Imperial College of Science, Technology and Medicine, Hammersmith Hospital, London, UK. Harrington.Kevin@mayo.edu
Lewanski
C R
CR
Stewart
J S
JS
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D004195:Disease Models, Animal; D004337:Drug Carriers; D006801:Humans; D008081:Liposomes; D009369:Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D004337:Drug Carriers; D008081:Liposomes